Abstract:The effectiveness of oral, mock-, and immersion vaccination was investigated against white spot syndrome virus (WSSV) in crayfish. The most exposed WSSV envelope proteins VP19 and VP28 were used in different compositions and with different modes of applications. In experiment 1 crayfish were fed recombinant protein coated food pellets for 25 days, in experiment 2 the purified proteins were directly injected to them followed by one booster dose on 5th day and in experiment 3 the crayfish were left immersed in vaccines for 7h. Experimental crayfish were challenged on 3rd and 21st days after last vaccination. The overall result showed that VP28 group has lowest cumulative mortality percentage accounting 39.6% at 3rd day and 39.83% at 21st day when injected and it was 43.2% and 49% when fed orally and 46.3% and 46.5% when immersed at 3rd and 21st days, respectively (p<0.05). In VP19 and VP28 (50:50) mixture, mock vaccination showed better performance (36.5%) over immersion (53%) and oral vaccination (53.2%) when challenged on 3rd day and mock vaccination (36.50%) followed by oral (51%) and immersion vaccination (56.5%) on 21st day as well. The VP19 recombinant mock vaccination group performed better (52.91% of 3rd day and 56.46% of 21st day) than oral (76% of 3rd day and 82% of 21st day) and immersion (83% of 3rd day and 86.3% of 21st day) vaccine groups. All the experimental groups except VP19 were significantly different (p<0.05) from the control groups. A positive cumulative effect was observed when VP28 was mixed with VP19 in equal proportion in all the experimental trials, which shows the effectiveness of VP19 as a vaccine component too. In the present trial on the basis of cumulative mortality percentage it is found that mock-vaccination group is more effective than the oral vaccination and immersion vaccination. It also suggests that specific memory exists in crayfish and the effects of VP28 are significant. The effect of VP19 along with VP28 has also shown significant effect against WSSV.

Effects of Oral Recombinant VP28 Expressed in Silkworm ( Bombyx Mori ) Pupa on Immune Response and Disease Resistance of Procambarus Clarkii

EFFECT OF WHITE SPOT SYNDROME VIRUS ENVELOPE PROTEIN Vp28 EXPRESSED IN SILKWORM (BOMBYX MORI) PUPAE ON DISEASE RESISTENCE IN PROCAMBARUS CLARKII

Swath-Based Quantitative Proteomics Reveals the Mechanism of Enhanced Bombyx Mori Nucleopolyhedrovirus-Resistance in Silkworm Reared on Uv-B Treated Mulberry Leaves

Research Article an Improved Bac-to-Bac/BmNPV Technology Expressing Envelope E2 Glycoprotein of Classical Swine Fever Virus (CSFV) in the Silkworm, Bombyx Mori

Crayfish Procambarus Clarkii Protected Against White Spot Syndrome Virus by Oral Administration of Viral Proteins Expressed in Silkworms

Increased resistance to white spot syndrome virus in Procambarus clarkii by injection of envelope protein VP28 expressed using recombinant baculovirus

Enhanced Effect of Fluorescent Whitening Agent on Peroral Infection for Recombinant Baculovirus in the Host Bombyx Mori L

Oral Vaccination Trials with Crayfish, Procambarus Clarkii, to Induce Resistance to the White Spot Syndrome Virus

The Expression of VP28 Gene from Prawn White Spot Syndrome Virus in Silkworm, Bombyx Mori

The expression of VP19 gene from prawn white spot syndrome virus in silkworm, Bombyx mori using host range-expanded HyNPV]

Surface-displayed VP28 on Bacillus subtilis spores induce protection against white spot syndrome virus in crayfish by oral administration.

The Efficacy of Recombinant Vaccines Against White Spot Syndrome Virus in Procambarus Clarkii.

Oral Vaccination with Envelope Protein VP28 Against White Spot Syndrome Virus in Procambarus Clarkii Using Bacillus Subtilis As Delivery Vehicles.

Enhanced antiviral immunity against Bombyx mori cytoplasmic polyhedrosis virus via overexpression of peptidoglycan recognition protein S2 in transgenic silkworms.

Antiviral Activity in the Mulberry Silkworm, Bombyx Mori L.

A Vector That Expresses VP28 of WSSV Can Protect Red Swamp Crayfish from White Spot Disease.

BmHSP19.9 Targeting P6.9 and VLF-1 to Mediate the Formation of Defective Progeny Viruses in the Silkworm Antiviral Variety 871C

Immune responses of Fenneropenaeus chinensis against white spot syndrome virus after oral delivery of VP28 using Bacillus subtilis as vehicles.

Transgenic Breeding of Anti-Bombyx Mori L. Nuclear Polyhedrosis Virus Silkworm Bombyx Mori.

Dietary Chitosan Nanoparticles Protect Crayfish Procambarus Clarkii Against White Spot Syndrome Virus (wssv) Infection

Productive infection of Autographa californica nucleopolyhedrovirus in silkworm Bombyx mori strain Haoyue due to the absence of a host antiviral factor.